Affiliation:
1. Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
Abstract
In traditional Chinese medicine (TCM) clinical practice,ZHENG(also known as syndrome) helps to guide design of individualized treatment strategies. In this study, we investigated the clinical use ofZHENGin TCM-treated cancer patients by systematically analyzing data from all relevant reports in the Chinese-language scientific literature. We aimed to determine the clinicalZHENGdistributions in six common cancers (lung, liver, gastric, breast, colorectal, and pancreatic) with the expectation of uncovering a theoretical basis for TCMZHENGas a clinical cancer treatment. In addition, we also reviewed the molecular basis underlyingXue-Yu(blood stasis),Shi-Re(dampness-heat),Yin-Xu(Yin deficiency), andPi-Xu(spleen deficiency)ZHENGthat are commonly found in cancer patients. The results from our summary study provide insights into the potential utility of TCMZHENGand may contribute to a better understanding of the molecular basis of TCMZHENGin cancer.
Funder
National Science Council Taiwan
Subject
Complementary and alternative medicine
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献